Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial #NBTintheNews thenextweb.com/news/insilic...

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial #NBTintheNews thenextweb.com/news/insilic...
Redesigned landing sites lift Bxb1 integration efficiency #NBTintheNews crisprmedicinenews.com/news/redesig...
AI-informed AdaptiveFlow redefines large-scale cloud computing for drug discovery #NBTintheNews via @stjuderesearch.bsky.social www.stjude.org/media-resour...
Engineered bacteria could speed rock weathering to combat climate change #NBTintheNews via @harvardmed.bsky.social hms.harvard.edu/news/enginee...
AI-designed drug appears to turn back the body's biological clock in early trial #NBTintheNews the-decoder.com/ai-designed-...
Early data indicates an AI-generated drug could slow aging #NBTintheNews www.nytimes.com/2026/09/07/s...
Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks #NBTintheNews insilico.com/news/rnt0709...